Published in Cancer Weekly, June 29th, 2010
"Electronic searches of PubMed and EMBASE were conducted to select studies. control studies containing available genotype frequencies of EGF 61A >G were chose, and Odds ratio (OR) with 95% confidence interval (CI) was used to assess the strength of this association. 23 case-control studies including 5578...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.